The Marlborough, MA-based company received CE mark for the valve in April. Boston Scientific gained access to Acurate when it closed its $435 million acquisition of Symetis.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,